15 Impairment charges / (reversals)
| Impairment charges / (reversals) comprise: | 2017 | 2016 | 2015 | |||||||||
|
Impairment charges on financial assets, excluding receivables |
74 | 117 | 95 | |||||||||
|
Impairment reversals on financial assets, excluding receivables |
(32 | ) | (58 | ) | (119 | ) | ||||||
|
Impairment charges and reversals on non-financial assets and receivables |
- | 36 | 1,275 | |||||||||
|
Total |
42 | 95 | 1,251 | |||||||||
In 2015, impairment charges and reversals on non-financial assets and receivables include a charge of EUR 1,274 million mainly related to deferred acquisition costs in the UK. Recoverability of capitalized deferred policy acquisition costs was affected by the restructuring of the organization.
| Impairment charges on financial assets, excluding receivables, from: | 2017 | 2016 | 2015 | |||||||||
|
Shares |
2 | 1 | 4 | |||||||||
|
Debt securities and money market instruments |
17 | 53 | 32 | |||||||||
|
Loans |
50 | 23 | 37 | |||||||||
|
Investments in associates |
4 | 7 | - | |||||||||
|
Investments in joint ventures |
- | - | 21 | |||||||||
|
Other |
- | 33 | - | |||||||||
|
Total |
74 | 117 | 95 | |||||||||
| Impairment reversals on financial assets, excluding receivables, from: | 2017 | 2016 | 2015 | |||||||||
|
Debt securities and money market instruments |
(17 | ) | (42 | ) | (109 | ) | ||||||
|
Loans |
(13 | ) | (14 | ) | (9 | ) | ||||||
|
Other |
(2 | ) | (2 | ) | - | |||||||
|
Total |
(32 | ) | (58 | ) | (119 | ) | ||||||
|
For more details on impairments on financial assets, excluding receivables, refer to note 4 Financial risks. |
||||||||||||